{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:29:00Z","timestamp":1761182940955,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020824","name":"Invasive Fungi Research Center, Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jiac.2018.07.018","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T21:23:55Z","timestamp":1537305835000},"page":"157-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["In-vitro antifungal susceptibility testing of lanoconazole and luliconazole against Aspergillus flavus as an important agent of\u00a0invasive aspergillosis"],"prefix":"10.1016","volume":"25","author":[{"given":"Saeed Mahdavi","family":"Omran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Taghizadeh-Armaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Zarrinfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6415-4648","authenticated-orcid":false,"given":"Mohammad T.","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Abastabar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Moqarabzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saham","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasan","family":"Saber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akbar","family":"Hoseinnejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Miri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedmojtaba","family":"Seyedmousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jiac.2018.07.018_bib1","first-page":"63","article-title":"Invasive aspergillosis in immunocompromised patients","volume":"75","author":"Kliasova","year":"2002","journal-title":"Terapevticheskii arkhiv"},{"issue":"6","key":"10.1016\/j.jiac.2018.07.018_bib2","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/mic.0.2007\/007641-0","article-title":"Aspergillus flavus: human pathogen, allergen and mycotoxin producer","volume":"153","author":"Hedayati","year":"2007","journal-title":"Microbiol"},{"issue":"5","key":"10.1016\/j.jiac.2018.07.018_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00004-17","article-title":"Genetic diversity and in\u00a0vitro antifungal susceptibility of 200 clinical and environmental Aspergillus flavus isolates","volume":"61","author":"Taghizadeh-Armaki","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jiac.2018.07.018_bib4","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/AAC.00942-07","article-title":"Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification","volume":"52","author":"Alcazar-Fuoli","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jiac.2018.07.018_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jiac.2018.07.018_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.jiac.2018.07.018_bib7","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3201\/eid1905.130075","article-title":"Azole-resistant Aspergillus fumigatus, Iran","volume":"19","author":"Seyedmousavi","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.jiac.2018.07.018_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ijantimicag.2008.06.018","article-title":"Molecular characterisation of cyp51A and cyp51B genes coding for P450 14\u03b1-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus","volume":"32","author":"Krishnan-Natesan","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"10.1016\/j.jiac.2018.07.018_bib9","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3109\/13693781003749418","article-title":"Aspergillus alliaceus and Aspergillus flavus co-infection in an acute myeloid leukemia patient","volume":"48","author":"Ozhak-Baysan","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.jiac.2018.07.018_bib10","series-title":"26th European congress of clinical microbiology and infectious diseases","article-title":"Prevalence of azole resistance in clinical Aspergillus flavus isolates: presence of novel S196F, A324P, N423D and V465M substitutions in the cyp51C gene","author":"Sharma","year":"2016"},{"issue":"4","key":"10.1016\/j.jiac.2018.07.018_bib11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s10156-004-0327-1","article-title":"In\u00a0vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agent","volume":"10","author":"Uchida","year":"2004","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2018.07.018_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/CE.S49629","article-title":"Luliconazole for the treatment of fungal infections: an evidence-based review","volume":"9","author":"Khanna","year":"2014","journal-title":"Core Evid"},{"issue":"11","key":"10.1016\/j.jiac.2018.07.018_bib13","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1128\/AAC.01193-16","article-title":"Potent activities of novel imidazoles lanoconazole and luliconazole against a collection of azole-resistant and-susceptible Aspergillus fumigatus strains","volume":"60","author":"Abastabar","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"year":"2008","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A2","author":"Clinical and Laboratory Standards Institute","key":"10.1016\/j.jiac.2018.07.018_bib14"},{"issue":"3","key":"10.1016\/j.jiac.2018.07.018_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0924-8579(99)00076-X","article-title":"Efficacy of NND-502, a novel imidazole antimycotic agent, in experimental models of Candida albicans and Aspergillus fumigatus infections","volume":"12","author":"Niwano","year":"1999","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18302393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18302393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:57:52Z","timestamp":1761159472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X18302393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1341321X18302393"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2018.07.018","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-vitro antifungal susceptibility testing of lanoconazole and luliconazole against Aspergillus flavus as an important agent of\u00a0invasive aspergillosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2018.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}